flestolol has been researched along with Coronary Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bell, V; Coe, J; Frishman, WH; Heilbrunn, S; Josephson, M; Osterle, S; Singh, B; Strom, J; Turlapaty, P; Viray, R | 1 |
1 other study(ies) available for flestolol and Coronary Disease
| Article | Year |
|---|---|
Hemodynamic effects of flestolol, a titratable short-acting intravenous beta-adrenergic receptor blocker.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Coronary Disease; Dose-Response Relationship, Drug; Female; Fluorobenzenes; Heart Ventricles; Hemodynamics; Humans; Male; Middle Aged; Propanolamines | 1988 |